98 related articles for article (PubMed ID: 3427318)
1. Biochemical picture accompanying sclerotic bone metastases of prostatic origin.
Minisola S; Perugia G; Scarda A; Scarnecchia L; Tuzzolo D; Rossi W; Mazzuoli G
Br J Urol; 1987 Nov; 60(5):443-6. PubMed ID: 3427318
[TBL] [Abstract][Full Text] [Related]
2. Renal tubular reabsorption of phosphate is positively related to the extent of bone metastatic load in patients with prostate cancer.
Buchs N; Bonjour JP; Rizzoli R
J Clin Endocrinol Metab; 1998 May; 83(5):1535-41. PubMed ID: 9589651
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid function and vitamin D status in patients with bone metastases of prostatic origin.
Charhon SA; Chapuy MC; Delvin EE; Meunier PJ
Miner Electrolyte Metab; 1985; 11(2):117-22. PubMed ID: 3838794
[TBL] [Abstract][Full Text] [Related]
4. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.
Nielsen HK; Thomsen K; Eriksen EF; Charles P; Storm T; Mosekilde L
Bone Miner; 1988 Apr; 4(1):105-13. PubMed ID: 3263890
[TBL] [Abstract][Full Text] [Related]
5. Renal threshold phosphate concentration (TmPO4/GFR).
Kruse K; Kracht U; Göpfert G
Arch Dis Child; 1982 Mar; 57(3):217-23. PubMed ID: 6280622
[TBL] [Abstract][Full Text] [Related]
6. Age-related changes in serum immunoreactive parathyroid hormone and its biological action in healthy men and women.
Endres DB; Morgan CH; Garry PJ; Omdahl JL
J Clin Endocrinol Metab; 1987 Oct; 65(4):724-31. PubMed ID: 2821053
[TBL] [Abstract][Full Text] [Related]
7. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
Alon U; Chan JC
J Clin Endocrinol Metab; 1984 Apr; 58(4):671-5. PubMed ID: 6546575
[TBL] [Abstract][Full Text] [Related]
8. Effects of phosphorus supplementation on serum parathyroid hormone and bone morphology in osteoporosis.
Goldsmith RS; Jowsey J; Dubé WJ; Riggs BL; Arnaud CD; Kelly PJ
J Clin Endocrinol Metab; 1976 Sep; 43(3):523-32. PubMed ID: 956340
[TBL] [Abstract][Full Text] [Related]
9. Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
Marx SJ; Spiegel AM; Brown EM; Windeck R; Gardner DG; Downs RW; Attie M; Aurbach GD
J Clin Endocrinol Metab; 1978 Dec; 47(6):1190-7. PubMed ID: 233692
[TBL] [Abstract][Full Text] [Related]
10. The maximal tubular reabsorption of phosphate in relation to serum parathyroid hormone.
Madsen S; Olgaard K; Ladefoged J
Adv Exp Med Biol; 1977; 81():141-8. PubMed ID: 899923
[TBL] [Abstract][Full Text] [Related]
11. Calcium and phosphate metabolism in acromegaly.
Halse J; Haugen HN
Acta Endocrinol (Copenh); 1980 Aug; 94(4):459-67. PubMed ID: 6254298
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease.
Pecherstorfer M; Zimmer-Roth I; Schilling T; Woitge HW; Schmidt H; Baumgartner G; Thiébaud D; Ludwig H; Seibel MJ
J Clin Endocrinol Metab; 1995 Jan; 80(1):97-103. PubMed ID: 7829646
[TBL] [Abstract][Full Text] [Related]
13. [Prostatic osteocondensing metastases and osteomalacia. Value of histomorphometric study. Preliminary results].
Coindre JM; Mage P; Bui BN; Goussot JF; De Mascarel I; De Mascarel A; Trojani M
Presse Med; 1985 Oct; 14(35):1823-7. PubMed ID: 2933667
[TBL] [Abstract][Full Text] [Related]
14. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
Offermann G; Schaefer K; Schulz A; Delling G
Klin Wochenschr; 1976 Jul; 54(13):625-32. PubMed ID: 940299
[TBL] [Abstract][Full Text] [Related]
15. Effect of age on serum immunoreactive parathyroid hormone and its biological effects.
Insogna KL; Lewis AM; Lipinski BA; Bryant C; Baran DT
J Clin Endocrinol Metab; 1981 Nov; 53(5):1072-5. PubMed ID: 6270181
[TBL] [Abstract][Full Text] [Related]
16. Dissociation between the effects of endogenous parathyroid hormone on adenosine 3',5'-monophosphate generation and phosphate reabsorption in hypocalcemia due to vitamin D depletion: an acquired disorder resembling pseudohypoparathyroidism type II.
Rao DS; Parfitt AM; Kleerekoper M; Pumo BS; Frame B
J Clin Endocrinol Metab; 1985 Aug; 61(2):285-90. PubMed ID: 2989317
[TBL] [Abstract][Full Text] [Related]
17. Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.
Kylmälä T; Tammela TL; Risteli L; Risteli J; Kontturi M; Elomaa I
Br J Cancer; 1995 May; 71(5):1061-4. PubMed ID: 7734300
[TBL] [Abstract][Full Text] [Related]
18. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
Portale AA; Booth BE; Halloran BP; Morris RC
J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D metabolites and bone mineralization in man.
Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
[TBL] [Abstract][Full Text] [Related]
20. Effects of a short course of estrogen on mineral metabolism in postmenopausal women.
Stock JL; Coderre JA; Mallette LE
J Clin Endocrinol Metab; 1985 Oct; 61(4):595-600. PubMed ID: 2993339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
